Adverse reactions in DMD patients N8 treated with EXONDYS 51 30 mg or 50 mgkgweek by intravenous IV infusion with an incidence of at least 25 more than placebo N4 Study 1 24 weeks were EXONDYS 51 placebo balance disorder 38 0 vomiting 38 0 and contact dermatitis 25 0